Innovent, Takeda ink up to US$ 11.4 bn oncology deal; FDA clears Novo’s Rybelsus to reduce heart risk in diabetics
In this week’s Phispers, China’s Innovent Biologics signed one of the largest cross-border biotech deals in Asia. U...
Impressions : 1561
CBER director forced out in FDA gutting; Sanofi, Alnylam’s RNAi therapy Qfitlia wins US approval for hemophilia A, B
The pharma industry saw its most tumultuous week in the recent past with the US Food and Drug Administration (FDA) facing an un...
Impressions : 1151
Recipharm’s UK facility fails GMP inspection; FDA proposes harmonization of standards for generic drugs
This week, Phispers brings you news on AstraZeneca’s Lynparza that has shown strong benefits for women with ovarian cance...
Impressions : 3528
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.